Local microwave ablation with continued EGFR tyrosine kinase inhibitor as a treatment strategy in advanced non-small cell lung cancers that developed extra-central nervous system oligoprogressive disease during EGFR tyrosine kinase inhibitor treatment: A pilot study

The non-small cell lung cancer (NSCLC) patients that experienced good clinical response to epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKIs) will ultimately develop acquired resistance. This retrospective study was performed to explore the potential survival benefit of microwave...

Descripción completa

Detalles Bibliográficos
Autores principales: Ni, Yang, Bi, Jingwang, Ye, Xin, Fan, Weijun, Yu, Guohua, Yang, Xia, Huang, Guanghui, Li, Wenhong, Wang, Jiao, Han, Xiaoying, Ni, Xiang, Wei, Zhigang, Han, Mingyong, Zheng, Aimin, Meng, Min, Xue, Guoliang, Zhang, Liang, Wan, Chao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998341/
https://www.ncbi.nlm.nih.gov/pubmed/27336903
http://dx.doi.org/10.1097/MD.0000000000003998

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998341/
https://www.ncbi.nlm.nih.gov/pubmed/27336903
http://dx.doi.org/10.1097/MD.0000000000003998

Ejemplares similares